Xenon Pharmaceuticals Share Price Today
(NASDAQ: XENE)

Name: Xenon Pharmaceuticals Share Price Today (NASDAQ: XENE) - Xenon Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Xenon Pharmaceuticals share price is $35.11 & ₹3,000.68 as on 18 Apr 2025, 2.30 'hrs' IST

$35.11

▲

1.33

(3.94%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Xenon Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Xenon Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xenon Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Xenon Pharmaceuticals share price movements

Today's Low: $33.55
Today's High: $35.40
$35.11
4.44%
Downside
Day's Volatility :5.23%
Upside
0.82%
52 Weeks Low: $26.74
52 Weeks High: $46.00
$35.11
23.84%
Downside
52 Weeks Volatility :41.87%
Upside
23.67%

Xenon Pharmaceuticals (XENE) Returns

Period	Xenon Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-9.93%	-2.8%	0.0%
6 Months	-20.58%	-11.0%	0.0%
1 Year	-11.96%	-1.9%	0.0%
3 Years	7.3%	-1.5%	-12.9%

Xenon Pharmaceuticals (XENE) Key Statistics

in dollars & INR

Previous Close	$33.78
Open	$33.71
Today's High	$35.4
Today's Low	$33.55
Market Capitalization	$2.7B
Today's Volume	$825.8K
52 Week High	$46.0
52 Week Low	$26.74
Revenue TTM	$0.0
EBITDA	$-276.7M
Earnings Per Share (EPS)	$-3.13
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-27.85%

How to invest in Xenon Pharmaceuticals Stock (XENE) from India?

It is very easy for Indian residents to invest directly in Xenon Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xenon Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xenon Pharmaceuticals or XENE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xenon Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xenon Pharmaceuticals shares which would translate to 0.024 fractional shares of Xenon Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xenon Pharmaceuticals, in just a few clicks!

Returns in Xenon Pharmaceuticals (XENE) for Indian investors in Rupees

The Xenon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Xenon Pharmaceuticals investment value today

Current value as on today

₹90,380

Returns

₹9,620

(-9.62%)

Returns from Xenon Pharmaceuticals Stock

₹11,961 (-11.96%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Xenon Pharmaceuticals (XENE)

-33%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Xenon Pharmaceuticals Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Xenon Pharmaceuticals

FMR Inc
9.83%
venBio Select Advisor LLC
7.40%
Driehaus Capital Management LLC
5.91%
Wellington Management Company LLP
4.94%
BRAIDWELL LP
3.81%
HHG PLC
3.75%

Analyst Recommendation on Xenon Pharmaceuticals

Rating

Trend

Buy

95%Buy

4%Hold

0%Sell

Based on 24 Wall street analysts offering stock ratings for Xenon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Xenon Pharmaceuticals Stock (XENE)

What analysts predicted

Upside of 63.24%

Target:

$57.31

Current:

$35.11

Insights on Xenon Pharmaceuticals Stock (Ticker Symbol: XENE)

Price Movement
In the last 7 days, XENE stock has moved up by 7.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 8.76K → 5.38M (in $), with an average increase of 99.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, -44.74M → -65.68M (in $), with an average decrease of 10.3% per quarter
XENE vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 91.4%
XENE vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 27.5%

Xenon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Xenon Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Xenon Pharmaceuticals (XENE) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Xenon Pharmaceuticals Inc	-3.07%	-20.58%	-11.96%	7.3%	167.81%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Xenon Pharmaceuticals Inc	NA	NA	-0.06	-4.05	-0.28	-0.2	NA	9.88
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Xenon Pharmaceuticals Inc	Buy	$2.7B	167.81%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

Xenon Pharmaceuticals Dividend announcements

Xenon Pharmaceuticals Earnings
Xenon Pharmaceuticals’s price-to-earnings ratio stands at None

About Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Organization	Xenon Pharmaceuticals
Employees	316
CEO	Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.
Industry	Health Technology

Management People of Xenon Pharmaceuticals

Name	Title
Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.	President, CEO & Director
Ms. Sherry Aulin C.A., CPA	Chief Financial Officer
Dr. Robin P. Sherrington Ph.D.	Executive Vice President of Strategy & Innovation
Dr. Christopher John Kenney M.D.	Chief Medical Officer
Dr. Matthew D. Ronsheim Ph.D.	Chief Operating Officer
Ms. Andrea DiFabio J.D.	Chief Legal Officer & Corporate Secretary
Ms. Shelley McCloskey B.A.	Executive Vice President of Human Resources
Dr. James R. Empfield Ph.D.	Executive Vice President of Drug Discovery

Important FAQs about investing in XENE Stock from India :

What is Xenon Pharmaceuticals share price today?

Xenon Pharmaceuticals share price today stands at $35.11, Open: $33.71 ; Previous Close: $33.78 ; High: $35.40 ; Low: $33.55 ; 52 Week High: $46.00 ; 52 Week Low: $26.74.

The stock opens at $33.71, after a previous close of $33.78. The stock reached a daily high of $35.40 and a low of $33.55, with a 52-week high of $46.00 and a 52-week low of $26.74.

Can Indians buy Xenon Pharmaceuticals shares?

Yes, Indians can invest in the Xenon Pharmaceuticals (XENE) from India.

With INDmoney, you can buy Xenon Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Xenon Pharmaceuticals at zero transaction cost.

How can I buy Xenon Pharmaceuticals shares from India?

It is very easy to buy Xenon Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xenon Pharmaceuticals (XENE) be purchased?

Yes, you can buy fractional shares of Xenon Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Xenon Pharmaceuticals stocks?

To start investing in Xenon Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.